What is important for people with nontuberculous mycobacterial disease?: An EMBARC-ELF patient survey

Michal Shteinberg; Jeanette Boyd; Stefano Aliberti; Eva Polverino; Bridget Harris; Tove Berg; Annette Posthumus; Thomas Ruddy; Pieter Goeminne; Ernie Lloyd; Timothy Alan; Josje Altenburg; Barbara Crossley; Francesco Blasi; James Chalmers

doi:10.1183/23120541.00807-2020

What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey

Michal Shteinberg, Jeanette Boyd, Stefano Aliberti, Eva Polverino, Bridget Harris, Tove Berg, Annette Posthumus, Thomas Ruddy, Pieter Goeminne, Ernie Lloyd, Timothy Alan, Josje Altenburg, Barbara Crossley, Francesco Blasi, James Chalmers

Pulmonary medicine

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Patients' experiences of NTM pulmonary disease highlight important and unmet needs for better pharmacological treatment and education of medical staff https://bit.ly/3mjrlwh.

Original language	English
Journal	ERJ Open Research
Volume	7
Issue number	1
DOIs	https://doi.org/10.1183/23120541.00807-2020
Publication status	Published - Jan 2021

Access to Document

10.1183/23120541.00807-2020

Cite this

Shteinberg, M., Boyd, J., Aliberti, S., Polverino, E., Harris, B., Berg, T., Posthumus, A., Ruddy, T., Goeminne, P., Lloyd, E., Alan, T., Altenburg, J., Crossley, B., Blasi, F., & Chalmers, J. (2021). What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey. ERJ Open Research, 7(1). https://doi.org/10.1183/23120541.00807-2020

Shteinberg, Michal ; Boyd, Jeanette ; Aliberti, Stefano ; Polverino, Eva ; Harris, Bridget ; Berg, Tove ; Posthumus, Annette ; Ruddy, Thomas ; Goeminne, Pieter ; Lloyd, Ernie ; Alan, Timothy ; Altenburg, Josje ; Crossley, Barbara ; Blasi, Francesco ; Chalmers, James. / What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey. In: ERJ Open Research. 2021 ; Vol. 7, No. 1.

@article{b9224ee8034149428c586f6f53940e44,

title = "What is important for people with nontuberculous mycobacterial disease?: An EMBARC-ELF patient survey",

abstract = "Patients' experiences of NTM pulmonary disease highlight important and unmet needs for better pharmacological treatment and education of medical staff https://bit.ly/3mjrlwh.",

author = "Michal Shteinberg and Jeanette Boyd and Stefano Aliberti and Eva Polverino and Bridget Harris and Tove Berg and Annette Posthumus and Thomas Ruddy and Pieter Goeminne and Ernie Lloyd and Timothy Alan and Josje Altenburg and Barbara Crossley and Francesco Blasi and James Chalmers",

note = "Copyright {\textcopyright}ERS 2021.",

year = "2021",

month = jan,

doi = "10.1183/23120541.00807-2020",

language = "English",

volume = "7",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

number = "1",

}

What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey. / Shteinberg, Michal; Boyd, Jeanette; Aliberti, Stefano; Polverino, Eva; Harris, Bridget; Berg, Tove; Posthumus, Annette; Ruddy, Thomas; Goeminne, Pieter; Lloyd, Ernie; Alan, Timothy; Altenburg, Josje; Crossley, Barbara; Blasi, Francesco; Chalmers, James.

In: ERJ Open Research, Vol. 7, No. 1, 01.2021.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - What is important for people with nontuberculous mycobacterial disease?

T2 - An EMBARC-ELF patient survey

AU - Shteinberg, Michal

AU - Boyd, Jeanette

AU - Aliberti, Stefano

AU - Polverino, Eva

AU - Harris, Bridget

AU - Berg, Tove

AU - Posthumus, Annette

AU - Ruddy, Thomas

AU - Goeminne, Pieter

AU - Lloyd, Ernie

AU - Alan, Timothy

AU - Altenburg, Josje

AU - Crossley, Barbara

AU - Blasi, Francesco

AU - Chalmers, James

PY - 2021/1

Y1 - 2021/1

N2 - Patients' experiences of NTM pulmonary disease highlight important and unmet needs for better pharmacological treatment and education of medical staff https://bit.ly/3mjrlwh.

AB - Patients' experiences of NTM pulmonary disease highlight important and unmet needs for better pharmacological treatment and education of medical staff https://bit.ly/3mjrlwh.

U2 - 10.1183/23120541.00807-2020

DO - 10.1183/23120541.00807-2020

M3 - Article

C2 - 33614773

VL - 7

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 1

ER -